Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy
Clinical trial NCT01280929 · COMPLETED
Trial details
- NCT number
- NCT01280929
- Sponsor
- José Cunha-Vaz
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.